Novo Nordisk reported DKK4.74 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q2 Jun/2026 4.74 5.14 5.96 Aug/05
FY2026Q1 Mar/2026 10.91 5.86 6.53 May/06
FY2025Q4 Dec/2025 6.04 5.89 6.34 Feb/04
FY2025Q3 Sep/2025 4.50 5.52 6.12 Sep/26
FY2025Q2 Jun/2025 5.96 6.00 4.49 Aug/06




Eps Change Date
Bausch Health Companies USD 1.26 0.48 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Eli Lilly USD 8.38 0.17 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Novo Nordisk DKK 4.74 6.17 Jun/2026
Novo Nordisk DKK 0.97 9.94 Jun/2026
Pacira USD 0.73 0.13 Jun/2026
Sanofi EUR 2.09 0.21 Jun/2026
Supernus Pharmaceuticals USD -1.01 1.61 Jun/2026